Professor Kazuhiro Matsuo (Division of Vaccinology for Clinical Development) has been selected for the “Resarch and Development of new generation vaccine including new modality Program ” funded by the Japan Agency for Medical Research and Development (AMED).

This program supports research and development aimed at addressing technical challenges necessary for applying novel modalities—expected to be utilized for infectious disease vaccines—to practical vaccine development. The adopted category is designed to promote the participation of researchers from different fields.

The research project of Professor Matsuo has been selected as follows:

Project Title:
Research and Development of a Booster Vaccine Targeting Adult Tuberculosis

This research aims to develop a booster vaccine for adult tuberculosis and is expected to contribute to the establishment of a novel vaccine platform that will play an important role in future tuberculosis control.